Results 251 to 260 of about 3,125,328 (279)

Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. [PDF]

Oncotarget
Zhang Y, Liu L, Fan P, Bauer N, Gladkich J, Ryschich E, Bazhin AV, Giese NA, Strobel O, Hackert T, Hinz U, Gross W, Fortunato F, Herr I.   +13 more
europepmc   +1 more source

Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. [PDF]

Biomedicines
Mendes I, Vale N.
europepmc   +1 more source

Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancreatic cancer. [PDF]

Heliyon
Ou G, Tian Z, Su M, Yu M, Gong J, Chen Y.   +5 more
europepmc   +1 more source

Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Albert Jang, Yousef Zakharia, Pedro C. Barata   +2 more
wiley   +1 more source

20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters. [PDF]

J Adv Res
Wu Y, Zhang J, Tian Y, Chi Shing Cho W, Xu HX, Lin ZX, Xian YF.   +6 more
europepmc   +1 more source

Abstracts

Cancer Science, Volume 117, Issue S1, Page 1-2148, January 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression

Digestive Diseases and Sciences, 2023
D. Wei, Liang Wang, Yi Liu, Margarete Hafley, L. Tan, P. Lorenzi, Peiying Yang, Xiangsheng Zuo, R. Bresalier   +8 more
semanticscholar   +1 more source

Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55

Biochemical Genetics, 2023
Linhai Fu, Zhupeng Li, Yuanlin Wu, Ting Zhu, Zhifeng Ma, Lingjun Dong, Jianyi Ding, Chu Zhang, Guangmao Yu   +8 more
semanticscholar   +1 more source

The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment

Nature Medicine, 2023
Yuan Wei, Yu-Pei Chen, Jiayi Shen
exaly  

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine, 2023
Matthew D Galsky, Sudeh Izadmehr, Edgar Ernesto Gonzalez Kozlova   +2 more
exaly